Abstract
Background and aims
Early neurological deterioration (END) in acute ischemic stroke (AIS), patients is defined as clinical worsening or recurrence during first 72 h after onset of AIS. We have conducted this study to determine the association between END and functional outcome at 3 months of onset of AIS along with associated risk factors of END in AIS cases.
Methodology
This study was conducted after approval of Institute Ethics Committee. Two hundred three consecutive patients were admitted from September 2020 to January 2022 at a tertiary care hospital. One hundred ninety patients were included in the study; patients were divided into two groups: (1) early neurological deterioration (END) and (2) non-early neurological deterioration (non-END). Patients were followed-up either telephonically or in person at approximately 3 months using modified Rankin Scale 0–6. All the clinically significant prognostic markers and p < 0.10 variables were considered significant in univariate analysis; P < 0.05 were considered statistically significant for the multivariate analysis.
Results
Out of 190 cases included in the cohort 34/190 (17.8%) cases showed END with mean age (56.56 (± 16.6)) and males (20/34 (58.8%)). END was independently associated with high blood glucose at admission (OR = 1.015; P = 0.002; 95%CI = 1.005–1.024) and low serum albumin (OR = 0.208; P = 0.002; 95%CI = 0.077–0.562). Patients with END showed poor functional outcome (mRS > 2) at end of 3 months (32 (94.1%); P < 0.001) and death was also statistically significant (22 (64.7%); P < 0.001) as compared to AIS cases having non-END.
Conclusion
Our study showed END may be associated with poor functional outcome in AIS patients. Higher blood glucose at admission and low serum albumin may be statistically significant causing END. Future prospective cohort with larger sample size may confirm the findings.
Similar content being viewed by others
Data availability
Data is available with us in anonymous form, maintaining the confidentiality of individual patients.
References
Global Burden of Disease 2017 (2018) Causes of death collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392:1736–1788
Directorate General of Health Services: Ministry of Health and Family Welfare (2019) National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke. Government of India. https://main.mohfw.gov.in/MajorProgrammes/non-communicable-diseases-injury-trauma/ Non-Communicable-Disease-II/National-Programmefor-Prevention-and-Control-of-Cancer-DiabetesCardiovascular-diseases-and-Stroke-NPCDCS (2019, accessed 21 September 2020)
Jones SP, Baqai K, Clegg A et al (2021) Stroke in India: a systematic review of the incidence, prevalence, and case fatality. Int J Stroke 17474930211027834. https://doi.org/10.1177/17474930211027834. Epub ahead of print. PMID: 34114912
Ferrari J, Knoflach M, Kiechl S et al (2010) Early clinical worsening in patients with TIA or minor stroke: the Austrian Stroke Unit Registry. Neurology 74:136–141
Thanvi B, Treadwell S, Robinson T (2008) Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad Med J 994:412–417
Roden-Jullig A (1997) Progressing stroke: epidemiology. Cerebrovasc Dis 7(suppl 5):2–5
Tei H, Uchiyama S, Ohara K et al (2000) Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project. Stroke 31:2049–2054
De Graba TJ, Hallenbeck JM, Pettigrew KD et al (1999) Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials. Stroke 30:1208–1212
Tanne D, Haim M, Goldbourt U et al (2003) Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke 34:632–636
Wityke RJ, Pessin MS, Kaplan RF et al (1994) Serial assessment of acute stroke using the NIH Stroke Scale. Stroke 25:362–365
Zhang X, Sun Z, Ding C et al (2016) Metabolic syndrome augments the risk of early neurological deterioration in acute ischemic stroke patients independent of inflammatory mediators: a hospital-based prospective study. Oxid Med Cell Longev 2016:8346301
Kim YD, Song D, Kim EH et al (2014) Long-term mortality according to the characteristics of early neurological deterioration in ischemic stroke patients. Yonsei Med J 55:669–675
Kim JT, Heo SH, Yoon W et al (2016) Clinical outcomes of patients with acute minor stroke receiving rescue IA therapy following early neurological deterioration. J NeuroIntervent Surg 8:461–465
Kwon HM, Lee YS, Bae HJ et al (2014) Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke. Stroke 45:871–873
Toni D, Fiorelli M, Gentile M et al (1995) Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis, and prognosis. Arch Neurol 52:670–675
Kwon HM, Lim JS, Park HK et al (2011) Hypertriglyceridemia as a possible predictor of early neurological deterioration in acute lacunar stroke. J Neurol Sci 309:128–130
Geng et al (2017) Early neurological deterioration during the acute phase as a predictor of long-term outcome after first-ever ischemic stroke. Medicine 96:51
Davalos A, Cendra E, Teruel J et al (1990) Deteriorating ischemic stroke: risk factors and prognosis. Neurology 40:1865–1869
Siegler JE, Boehme AK, Kumar AD et al (2013) What change in the national institutes of health stroke scale should define neurologic deterioration in acute ischemic stroke? J Stroke Cerebrovasc Dis 22:675–682
Vila N, Castillo J, Dávalos A, Chamorro A (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31:2325–2329
Lin LC, Yang JT, Weng HH et al (2011) Predictors of early clinical deterioration after acute ischemic stroke. Am J Emerg Med 29:577–581
Kwan J, Hand P (2006) Early neurological deterioration in acute stroke: clinical characteristics and impact on outcome. QJM 99:625–633
Bhatia K, Mohanty S, Tripathy BK et al (2015) Predictors of early neurological deterioration in patients with acute ischaemic stroke with special reference to blood urea nitrogen (BUN)/creatinine ratio & urine specific gravity. Indian J Med Res 141:299–307
Barber M, Wright F, Stott DJ et al (2004) Predictors of early neurological deterioration after ischaemic stroke: a case-control study. Gerontology 50:102–109
Potter J, Robinson T, Ford G et al (2005) for the CHHIPS Trial Group. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) pilot trial: rationale and design. J Hypertens 23:649–55
The ENOS Trial Investigators (2006) Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 1:245–9
COSSACS Trial Group (2005) COSSACS (Continue or Stop Post-Stroke Antihypertensives Collaborative Study): rationale and design. J Hypertens 23:455–458
Lindsberg PJ, Roine RO (2004) Hyperglycemia in acute stroke. Stroke 35:363–364
Parsons MW, Barber PA, Desmond PM et al (2002) Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 52:20–28
Kase CS, Furlan AJ, Wechsler LR et al (2001) Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 57:1603–1610
Candelise L, Landi G, Orazio EN et al (1985) Prognostic significance of hyperglycemia in acute stroke. Arch Neurol 42:661–663
Gray CS, Hildreth AJ, Sandercock PA et al (2007) for the GIST Trialists Collaboration. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 6:397–406
Bruno A, Biller J, Adams HP Jr et al (1999) for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Acute blood glucose level and outcome from ischemic stroke. Neurology 52:280–284
Bruno A, Levine SR, Frankel MR et al (2002) for the NINDS rt-PA Stroke Study Group. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59:669–674
Jorgensen HS, Nakayama H, Raaschou HO et al (1994) Effect of blood pressure and diabetes on stroke in progression. Lancet 344:156–159
Baird TA, Parsons MW, Phanh T et al (2003) Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 34:2208–2214
Weimar C, Mieck T, Buchthal J et al (2005) for the German Stroke Study Collaboration. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol 62:393–7
Rajajee V, Kidwell C, Starkman S et al (2006) Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology 67:980–984
Castillo J, Leira R, Garcia MM et al (2004) Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 35:520–526
Britton M, Roden A (1985) Progression of stroke after arrival at hospital. Stroke 16:629–632
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sharma, A., Pandit, A.K., Mishra, B. et al. Early neurological deterioration in acute ischemic stroke. Ir J Med Sci 193, 949–955 (2024). https://doi.org/10.1007/s11845-023-03485-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-023-03485-5